# Synthetic drugs (medicinal chemistry): Materials

Source page: https://www.materialinsights.org/technologies/synthetic_drugs/tech-materials/

#### Materials it needs

The commodities and chemicals it needs per unit, its share of each one's demand and how critical each is
 Uses 4

- [Phe Phenol and acetone](https://www.materialinsights.org/chemicals/phenol/) criticality low Salicylic acid, the starting point of aspirin, is made industrially from phenol by the Kolbe-Schmitt reaction ^[6]; many other drugs also start from aromatic chemicals.
- [AcOH Acetic acid](https://www.materialinsights.org/chemicals/acetic_acid/) criticality low Aspirin is made from salicylic acid and acetic anhydride ^[1], a derivative of acetic acid.
- [KSM Pharma starting materials and intermediates](https://www.materialinsights.org/chemicals/ksm_intermediates/) criticality medium Key starting materials and intermediates are the building blocks bought in to make active ingredients; much of their supply is overseas for the US market ^[7].
- [Exc Pharmaceutical excipients](https://www.materialinsights.org/chemicals/excipients/) criticality low Fillers, binders and coatings turn the active ingredient into tablets and capsules.
 Makes

- [API Small-molecule APIs](https://www.materialinsights.org/chemicals/apis/) criticality medium The product of medicinal chemistry is the active pharmaceutical ingredient.

as of 2026-11-10. No source gives material amounts per dose; criticality is the writer's judgement. Starting materials and active ingredients rank medium because most of the factories supplying the US market are abroad [7].

#### Critical materials

The materials whose supply could hold it back

- Bulk chemicals such as phenol and acetic acid are made in very large amounts for other uses, so they are unlikely to hold drug making back.
- Active ingredients: in 2019, 72% of the facilities making them for the US market were abroad, 13% in China and 18% in India, and the FDA warned that this reliance creates vulnerabilities ^[7].

as of 2026-11-10

#### Sources

1. [Aspirin (Brands with history)](https://dpma.de/english/our_office/publications/milestones/brandswithhistory/aspirin/index.html) German Patent and Trade Mark Office (DPMA)
2. [Kolbe-Schmitt reaction (Kolbe process), Illustrated Glossary of Organic Chemistry](https://www.chem.ucla.edu/~harding/IGOC/K/kolbe_schmitt_reaction.html) University of California, Los Angeles, Department of Chemistry and Biochemistry
3. [Safeguarding Pharmaceutical Supply Chains in a Global Economy (testimony of Janet Woodcock)](https://www.fda.gov/news-events/congressional-testimony/safeguarding-pharmaceutical-supply-chains-global-economy-10302019) US Food and Drug Administration, 2019

## Other sections

- [Summary](https://www.materialinsights.org/technologies/synthetic_drugs/index.md)
- [Overview](https://www.materialinsights.org/technologies/synthetic_drugs/tech-overview/index.md)
- [Science](https://www.materialinsights.org/technologies/synthetic_drugs/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/synthetic_drugs/tech-evolution/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/synthetic_drugs/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/synthetic_drugs/tech-industries/index.md)
